Authors:
COHEN I
BERNHEIM J
FISHMAN A
SHAPIRA J
TEPPER R
BEYTH Y
CORDOBA M
YIGAEL D
ALTARAS MM
Citation: I. Cohen et al., ESTROGEN AND PROGESTERONE RECEPTORS IN BENIGN OVARIAN-TUMORS OF MENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Gynecologic and obstetric investigation, 46(2), 1998, pp. 116-122
Authors:
COHEN I
BEYTH Y
BERNHEIM J
SHAPIRA J
CORDOBA M
AVIRAM R
FIGER A
YIGAEL D
ALTARAS MM
Citation: I. Cohen et al., DIFFERENT COEXISTING GYNECOLOGICAL AND ENDOMETRIAL PATHOLOGIES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Gynecologic and obstetric investigation, 46(2), 1998, pp. 123-129
Authors:
COHEN I
SHAPIRA J
BEYTH Y
BERNHEIM J
TEPPER R
CORDOBA M
ALTARAS MM
Citation: I. Cohen et al., ESTROGEN AND PROGESTERONE RECEPTORS OF ADENOMYOSIS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Gynecologic and obstetric investigation, 45(2), 1998, pp. 126-131
Authors:
COHEN I
BEYTH Y
SHAPIRA J
TEPPER R
FISHMAN A
CORDOBA M
BERNHEIM J
YIGAEL D
ALTARAS MM
Citation: I. Cohen et al., HIGH-FREQUENCY OF ADENOMYOSIS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Gynecologic and obstetric investigation, 44(3), 1997, pp. 200-205
Authors:
COHEN I
ALTARAS MM
SHAPIRA J
TEPPER R
CORDOBA M
FIGER A
ZALEL Y
DROR Y
BEYTH Y
Citation: I. Cohen et al., DIFFERENT COEXISTING ENDOMETRIAL HISTOLOGICAL FEATURES IN ASYMPTOMATIC POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Gynecologic and obstetric investigation, 43(1), 1997, pp. 60-63
Authors:
COHEN I
BEYTH Y
ALTARAS MM
SHAPIRA J
TEPPER R
CARDOBA M
YIGAEL D
FIGER A
FISHMAN A
BERENHEIN J
Citation: I. Cohen et al., ESTROGEN AND PROGESTERONE-RECEPTOR EXPRESSION IN POSTMENOPAUSAL TAMOXIFEN-EXPOSED ENDOMETRIAL PATHOLOGIES, Gynecologic oncology, 67(1), 1997, pp. 8-15
Authors:
COHEN I
ALTARAS MM
BEYTH Y
SHAPIRA J
FIGER A
TEPPER R
CORDOBA M
YIGAL D
BERNHEIM J
Citation: I. Cohen et al., ESTROGEN AND PROGESTERONE RECEPTORS IN THE ENDOMETRIUM OF POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN AND PROGESTOGENS, Gynecologic oncology, 65(1), 1997, pp. 83-88
Authors:
TEPPER R
BEYTH Y
ALTAREAS MM
ZALEL Y
SHAPIRA J
CORDOBA M
COHEN I
Citation: R. Tepper et al., VALUE OF SONOHYSTEROGRAPHY IN ASYMPTOMATIC POSTMENOPAUSAL TAMOXIFEN-TREATED PATIENTS, Gynecologic oncology, 64(3), 1997, pp. 386-391
Authors:
COHEN I
ALTARAS MM
BEYTH Y
ZALEL Y
SHAPIRA J
YIGAEL D
TEPPER R
Citation: I. Cohen et al., OVARIAN VOLUME IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Gynecologic oncology, 64(1), 1997, pp. 105-108
Authors:
SREDNI B
TICHLER T
SHANI A
SHAPIRA J
BRUDERMAN I
ALBECK M
KALECHMAN Y
Citation: B. Sredni et al., BONE-MARROW SPARING AND PREVENTION OF ALOPECIA BY AS101 IN A RANDOMIZED PHASE-II STUDY ON NSCL CANCER-PATIENTS TREATED WITH CARBOPLATIN ANDETOPOSIDE, Experimental hematology, 24(9), 1996, pp. 351-351
Authors:
COHEN I
ALTARAS MM
SHAPIRA J
TEPPER R
ROSEN DJD
CORDOBA M
ZALEL Y
FIGER A
YIGAEL D
BEYTH Y
Citation: I. Cohen et al., TIME-DEPENDENT EFFECT OF TAMOXIFEN THERAPY ON ENDOMETRIAL PATHOLOGY IN ASYMPTOMATIC POSTMENOPAUSAL BREAST-CANCER PATIENTS, International journal of gynecological pathology, 15(2), 1996, pp. 152-157
Authors:
COHEN I
FIGER A
ALTARAS MM
TEPPER R
SHAPIRA J
CORDOBA M
YIGAEL D
ARBEL Y
BEYTH Y
Citation: I. Cohen et al., COMMON ENDOMETRIAL DECIDUAL REACTION IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN AND PROGESTOGENS, International journal of gynecological pathology, 15(1), 1996, pp. 17-22
Authors:
COHEN I
BEYTH Y
TEPPER R
SHAPIRA J
ZALEL Y
FIGER A
CORDOBA M
YIGAEL D
ALTARAS MM
Citation: I. Cohen et al., OVARIAN-TUMORS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Gynecologic oncology, 60(1), 1996, pp. 54-58
Citation: Am. Baruchin et al., A SIMPLE, VERSATILE RETRACTOR FOR EAR, TONGUE, AND LIP SURGERY, Plastic and reconstructive surgery, 98(6), 1996, pp. 1116-1117
Authors:
SHAPIRA J
HOLAN G
BOTZER E
KUPIEZTKY A
TAL E
FUKS AB
Citation: J. Shapira et al., THE EFFECTIVENESS OF MIDAZOLAM AND HYDROXYZINE AS SEDATIVE AGENTS FORYOUNG PEDIATRIC DENTAL PATIENTS, Journal of dentistry for children, 63(6), 1996, pp. 421
Authors:
SREDNI B
XU RH
ALBECK M
GAFTER U
GAL R
SHANI A
TICHLER T
SHAPIRA J
BRUDERMAN I
CATANE R
KAUFMAN B
WHISNANT JK
METTINGER KL
KALECHMAN Y
Citation: B. Sredni et al., THE PROTECTIVE ROLE OF THE IMMUNOMODULATOR AS101 AGAINST CHEMOTHERAPY-INDUCED ALOPECIA STUDIES ON HUMAN AND ANIMAL-MODELS, International journal of cancer, 65(1), 1996, pp. 97-103
Authors:
KLEIN B
LEVIN I
KFIR B
MISHAELI M
SHAPIRA J
KLEIN T
Citation: B. Klein et al., THE SIGNIFICANCE OF SOLUBLE INTERLEUKIN-2, SOLUBLE INTERLEUKIN-2 RECEPTORS, SOLUBLE ICAM-1 AND BETA(2)-MICROGLOBULIN IN BREAST-CANCER PATIENTS, Tumor biology, 16(5), 1995, pp. 290-296
Citation: J. Shapira et al., RETROSPECTIVE EPIDEMIOLOGIC-STUDY OF BURKITTS-LYMPHOMA IN ISRAEL AND DIAGNOSIS BY A CONSERVATIVE INCISIONAL BIOPSY, European journal of cancer. Part B, Oral oncology, 31B(5), 1995, pp. 319-322
Authors:
SREDNI B
ALBECK M
TICHLER T
SHANI A
SHAPIRA J
BRUDERMAN I
CATANE R
KAUFMAN B
KALECHMAN Y
Citation: B. Sredni et al., BONE MARROW-SPARING AND PREVENTION OF ALOPECIA BY AS1O1 IN NON-SMALL-CELL LUNG-CANCER PATIENTS TREATED WITH CARBOPLATIN AND ETOPOSIDE, Journal of clinical oncology, 13(9), 1995, pp. 2342-2353